Added to YB: 2023-10-16
Pitch date: 2023-10-16
KRTX:US [bullish]
Karuna Therapeutics, Inc.
+87.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions.
Market Cap
$12.6B
Pitch Price
$175.56
Price Target
N/A
Dividend
N/A
EV/EBITDA
-23.17
P/E
-28.11
EV/Sales
17.3K
Sector
Biotechnology
Category
N/A
Show full summary:
Karuna Therapeutics, Inc. KRTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)